Start your Trading & Investing Journey with us
Join our channel for Daily Free Trades with Live analysis on Youtube, Trade Setup with Important Levels, and Important Stock Market Updates
Asston Pharmaceuticals IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details
Asston Pharmaceuticals IPO : Key Performance Indicators, PE Ratio, EPS, ROE, ROCE & RoNW
The Company Key Performance Indicates the pre-issue EPS of ₹ 6.9 and post-issue EPS of ₹ 5.08 for FY24. The pre-issue P/E ratio is 17.83x, while the post-issue P/E ratio is 24.21x. The company's ROCE for FY24 is 51.25%, ROE for FY24 is 50.56% and RoNW is 40.36%. The Annualised EPS is ₹ 9.32 and the Annualised P/E Ratios is 13.20x. These metrics suggest that the IPO is fully priced.
Key Performance Indicator
| KPI | Values |
|---|---|
| EPS Pre IPO (Rs.) | ₹ 6.9 |
| EPS Post IPO (Rs.) | ₹ 5.08 |
| Adjusted 12M EPS Post IPO (Rs.) | |
| P/E Pre IPO | 17.83 |
| P/E Post IPO | 24.21 |
| Adjusted 12M P/E Post IPO | |
| ROE | 50.56 % |
| ROCE | 51.25 % |
| P/BV | 7.20 |
| Debt/Equity | 0.68 |
| RoNW | 40.36 % |
| EBITDA Margin | |
| PAT Margin |
© 2022 CA Abhay Varn. All Rights Reserved Abhayvarn.com
